Qishen Yiqi Dripping Pill Protects Against Diabetic Nephropathy by Inhibiting the Wnt/β-Catenin and Transforming Growth Factor-β/Smad Signaling Pathways in Rats

Diabetic nephropathy is a severe microvascular complication of diabetes. Qishen Yiqi dripping pill (QYDP) has been reported to be a renal protective drug. However, the mechanisms remain unclear. This study was performed to investigate the mechanisms. In this study, Sprague-Dawley rats were injected...

Full description

Bibliographic Details
Main Authors: Qian Zhang, Xinhua Xiao, Jia Zheng, Ming Li, Miao Yu, Fan Ping, Tong Wang, Xiaojing Wang
Format: Article
Language:English
Published: Frontiers Media S.A. 2021-02-01
Series:Frontiers in Physiology
Subjects:
Wnt
Online Access:https://www.frontiersin.org/articles/10.3389/fphys.2020.613324/full
id doaj-1b0955b102c149108fc13c64f21adf55
record_format Article
spelling doaj-1b0955b102c149108fc13c64f21adf552021-02-19T06:21:31ZengFrontiers Media S.A.Frontiers in Physiology1664-042X2021-02-011110.3389/fphys.2020.613324613324Qishen Yiqi Dripping Pill Protects Against Diabetic Nephropathy by Inhibiting the Wnt/β-Catenin and Transforming Growth Factor-β/Smad Signaling Pathways in RatsQian ZhangXinhua XiaoJia ZhengMing LiMiao YuFan PingTong WangXiaojing WangDiabetic nephropathy is a severe microvascular complication of diabetes. Qishen Yiqi dripping pill (QYDP) has been reported to be a renal protective drug. However, the mechanisms remain unclear. This study was performed to investigate the mechanisms. In this study, Sprague-Dawley rats were injected with streptozotocin to generate a diabetes model. Diabetic rats were administered 150 or 300 mg/kg/day QYDP. After 8 weeks of treatment, serum creatinine, serum blood urea nitrogen, and 24-h urinary albumin were measured. Kidney histological staining and immunostaining were analyzed. Then, the renal tissue was analyzed with a genome expression array. The results showed that QYDP treatment reduced serum creatinine, blood urea nitrogen, and 24-h urinary albumin and improved kidney histology and fibrosis. The gene array revealed that the expression of 189 genes was increased, and that of 127 genes was decreased in the high dosage QYDP group compared with the diabetic group. Pathway and gene ontology analyses showed that the differentially expressed genes were involved in the Wnt/β-catenin and transforming growth factor-β (TGF-β)/Smad2 signaling pathways. QYDP reduced the renal Wnt1, catenin β1, Tgfb1, and Smad2 gene expression and β-catenin, TGF-β, Smad2, collagen I, α-smooth muscle actin, and fibronectin protein expression in diabetic rats. Our results provide the first evidence that QYDP performs its renal-protective function by inhibiting the Wnt/β-catenin and TGF-β/Smad2 signaling pathways in diabetic rats.https://www.frontiersin.org/articles/10.3389/fphys.2020.613324/fullTGF-βSmadβ-catenindiabetic nephropathyWnt
collection DOAJ
language English
format Article
sources DOAJ
author Qian Zhang
Xinhua Xiao
Jia Zheng
Ming Li
Miao Yu
Fan Ping
Tong Wang
Xiaojing Wang
spellingShingle Qian Zhang
Xinhua Xiao
Jia Zheng
Ming Li
Miao Yu
Fan Ping
Tong Wang
Xiaojing Wang
Qishen Yiqi Dripping Pill Protects Against Diabetic Nephropathy by Inhibiting the Wnt/β-Catenin and Transforming Growth Factor-β/Smad Signaling Pathways in Rats
Frontiers in Physiology
TGF-β
Smad
β-catenin
diabetic nephropathy
Wnt
author_facet Qian Zhang
Xinhua Xiao
Jia Zheng
Ming Li
Miao Yu
Fan Ping
Tong Wang
Xiaojing Wang
author_sort Qian Zhang
title Qishen Yiqi Dripping Pill Protects Against Diabetic Nephropathy by Inhibiting the Wnt/β-Catenin and Transforming Growth Factor-β/Smad Signaling Pathways in Rats
title_short Qishen Yiqi Dripping Pill Protects Against Diabetic Nephropathy by Inhibiting the Wnt/β-Catenin and Transforming Growth Factor-β/Smad Signaling Pathways in Rats
title_full Qishen Yiqi Dripping Pill Protects Against Diabetic Nephropathy by Inhibiting the Wnt/β-Catenin and Transforming Growth Factor-β/Smad Signaling Pathways in Rats
title_fullStr Qishen Yiqi Dripping Pill Protects Against Diabetic Nephropathy by Inhibiting the Wnt/β-Catenin and Transforming Growth Factor-β/Smad Signaling Pathways in Rats
title_full_unstemmed Qishen Yiqi Dripping Pill Protects Against Diabetic Nephropathy by Inhibiting the Wnt/β-Catenin and Transforming Growth Factor-β/Smad Signaling Pathways in Rats
title_sort qishen yiqi dripping pill protects against diabetic nephropathy by inhibiting the wnt/β-catenin and transforming growth factor-β/smad signaling pathways in rats
publisher Frontiers Media S.A.
series Frontiers in Physiology
issn 1664-042X
publishDate 2021-02-01
description Diabetic nephropathy is a severe microvascular complication of diabetes. Qishen Yiqi dripping pill (QYDP) has been reported to be a renal protective drug. However, the mechanisms remain unclear. This study was performed to investigate the mechanisms. In this study, Sprague-Dawley rats were injected with streptozotocin to generate a diabetes model. Diabetic rats were administered 150 or 300 mg/kg/day QYDP. After 8 weeks of treatment, serum creatinine, serum blood urea nitrogen, and 24-h urinary albumin were measured. Kidney histological staining and immunostaining were analyzed. Then, the renal tissue was analyzed with a genome expression array. The results showed that QYDP treatment reduced serum creatinine, blood urea nitrogen, and 24-h urinary albumin and improved kidney histology and fibrosis. The gene array revealed that the expression of 189 genes was increased, and that of 127 genes was decreased in the high dosage QYDP group compared with the diabetic group. Pathway and gene ontology analyses showed that the differentially expressed genes were involved in the Wnt/β-catenin and transforming growth factor-β (TGF-β)/Smad2 signaling pathways. QYDP reduced the renal Wnt1, catenin β1, Tgfb1, and Smad2 gene expression and β-catenin, TGF-β, Smad2, collagen I, α-smooth muscle actin, and fibronectin protein expression in diabetic rats. Our results provide the first evidence that QYDP performs its renal-protective function by inhibiting the Wnt/β-catenin and TGF-β/Smad2 signaling pathways in diabetic rats.
topic TGF-β
Smad
β-catenin
diabetic nephropathy
Wnt
url https://www.frontiersin.org/articles/10.3389/fphys.2020.613324/full
work_keys_str_mv AT qianzhang qishenyiqidrippingpillprotectsagainstdiabeticnephropathybyinhibitingthewntbcateninandtransforminggrowthfactorbsmadsignalingpathwaysinrats
AT xinhuaxiao qishenyiqidrippingpillprotectsagainstdiabeticnephropathybyinhibitingthewntbcateninandtransforminggrowthfactorbsmadsignalingpathwaysinrats
AT jiazheng qishenyiqidrippingpillprotectsagainstdiabeticnephropathybyinhibitingthewntbcateninandtransforminggrowthfactorbsmadsignalingpathwaysinrats
AT mingli qishenyiqidrippingpillprotectsagainstdiabeticnephropathybyinhibitingthewntbcateninandtransforminggrowthfactorbsmadsignalingpathwaysinrats
AT miaoyu qishenyiqidrippingpillprotectsagainstdiabeticnephropathybyinhibitingthewntbcateninandtransforminggrowthfactorbsmadsignalingpathwaysinrats
AT fanping qishenyiqidrippingpillprotectsagainstdiabeticnephropathybyinhibitingthewntbcateninandtransforminggrowthfactorbsmadsignalingpathwaysinrats
AT tongwang qishenyiqidrippingpillprotectsagainstdiabeticnephropathybyinhibitingthewntbcateninandtransforminggrowthfactorbsmadsignalingpathwaysinrats
AT xiaojingwang qishenyiqidrippingpillprotectsagainstdiabeticnephropathybyinhibitingthewntbcateninandtransforminggrowthfactorbsmadsignalingpathwaysinrats
_version_ 1724261591481843712